JPS6315861B2 - - Google Patents
Info
- Publication number
- JPS6315861B2 JPS6315861B2 JP17401481A JP17401481A JPS6315861B2 JP S6315861 B2 JPS6315861 B2 JP S6315861B2 JP 17401481 A JP17401481 A JP 17401481A JP 17401481 A JP17401481 A JP 17401481A JP S6315861 B2 JPS6315861 B2 JP S6315861B2
- Authority
- JP
- Japan
- Prior art keywords
- plasma
- hollow fiber
- blood
- fiber membrane
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000002381 plasma Anatomy 0.000 claims description 99
- 239000012510 hollow fiber Substances 0.000 claims description 66
- 239000012528 membrane Substances 0.000 claims description 66
- 210000004369 blood Anatomy 0.000 claims description 35
- 239000008280 blood Substances 0.000 claims description 35
- 238000000926 separation method Methods 0.000 claims description 35
- 210000000601 blood cell Anatomy 0.000 claims description 31
- 238000001914 filtration Methods 0.000 claims description 31
- 238000012545 processing Methods 0.000 claims description 15
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 13
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 13
- 230000035699 permeability Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 8
- 108010074605 gamma-Globulins Proteins 0.000 claims description 8
- 229920001903 high density polyethylene Polymers 0.000 claims description 8
- 239000004700 high-density polyethylene Substances 0.000 claims description 8
- 239000012888 bovine serum Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 12
- 239000011148 porous material Substances 0.000 description 10
- 239000004698 Polyethylene Substances 0.000 description 9
- -1 polyethylene Polymers 0.000 description 9
- 229920000573 polyethylene Polymers 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000007788 liquid Substances 0.000 description 5
- 238000002074 melt spinning Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 210000001724 microfibril Anatomy 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 230000001112 coagulating effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000009852 coagulant defect Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17401481A JPS5875555A (ja) | 1981-10-30 | 1981-10-30 | 血液処理装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17401481A JPS5875555A (ja) | 1981-10-30 | 1981-10-30 | 血液処理装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5875555A JPS5875555A (ja) | 1983-05-07 |
| JPS6315861B2 true JPS6315861B2 (ko) | 1988-04-06 |
Family
ID=15971126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17401481A Granted JPS5875555A (ja) | 1981-10-30 | 1981-10-30 | 血液処理装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5875555A (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142861A (ja) * | 1983-12-29 | 1985-07-29 | 三菱レイヨン株式会社 | ウイルスを除去する方法 |
| EP0183103B1 (en) * | 1984-11-09 | 1988-08-03 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Flat permeable membrane and method for manufacture thereof |
| CA1312429C (en) * | 1985-08-29 | 1993-01-12 | Yukio Seita | Porous membrane for separation of blood components and method for manufacture thereof |
-
1981
- 1981-10-30 JP JP17401481A patent/JPS5875555A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5875555A (ja) | 1983-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940008074B1 (ko) | 폴리프로필렌 다공질막 | |
| US4708799A (en) | Hollow fiber membrane for plasma separation | |
| CN1125669C (zh) | 聚砜中空纤维膜，其制法和用途 | |
| JPH06505640A (ja) | 整流透析器、膜及び方法 | |
| US4839055A (en) | Method for treating blood and apparatus therefor | |
| JP4190079B2 (ja) | 血液浄化用中空糸膜および中空糸膜型人工腎臓 | |
| JP2002526172A (ja) | 生物学的流体フィルターおよびシステム | |
| JPH10230148A (ja) | 半透膜 | |
| CN106659834B (zh) | 用于去除血液中的促炎介质以及粒细胞和单核细胞的系统 | |
| JPS6315861B2 (ko) | ||
| JPH10118472A (ja) | 中空糸膜及びその製造方法 | |
| JPS6388007A (ja) | ウイルスフリ−モジユ−ル | |
| JP4810720B2 (ja) | 選択除去膜およびそれを用いた血液処理器 | |
| JPH09308685A (ja) | 血液浄化用中空糸膜及び血液浄化器 | |
| JP5062773B2 (ja) | 血液浄化器 | |
| JPH0211263B2 (ko) | ||
| JP4003982B2 (ja) | ポリスルホン系選択透過性分離膜 | |
| JP5226587B2 (ja) | 高性能血液浄化器 | |
| Cencič et al. | Porcine blood cell separation by porous cellulose acetate membranes | |
| JP2967205B2 (ja) | 微粒子除去フィルター付きエアートラップ | |
| JPS60142861A (ja) | ウイルスを除去する方法 | |
| JP2612851B2 (ja) | 採漿器 | |
| JPS6337973Y2 (ko) | ||
| JPH01113068A (ja) | 血漿分離装置 | |
| JPS63104615A (ja) | ウイルスフリ−モジユ−ル |